Skip to main content

Peer Review reports

From: Real-world experience with calcitonin gene-related peptide-targeted antibodies for migraine prevention: a retrospective observational cohort study at two Japanese headache centers

Original Submission
28 Oct 2023 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
31 Oct 2023 Reviewed Reviewer Report - Lanfranco Pellesi
10 Nov 2023 Reviewed Reviewer Report - Eleonora de Matteis
19 Dec 2023 Author responded Author comments - Mamoru Shibata
Resubmission - Version 3
19 Dec 2023 Submitted Manuscript version 3
20 Dec 2023 Author responded Author comments - Mamoru Shibata
Resubmission - Version 4
20 Dec 2023 Submitted Manuscript version 4
21 Dec 2023 Author responded Author comments - Mamoru Shibata
Resubmission - Version 5
21 Dec 2023 Submitted Manuscript version 5
21 Dec 2023 Author responded Author comments - Mamoru Shibata
Resubmission - Version 6
21 Dec 2023 Submitted Manuscript version 6
21 Dec 2023 Author responded Author comments - Mamoru Shibata
Resubmission - Version 7
21 Dec 2023 Submitted Manuscript version 7
Publishing
22 Dec 2023 Editorially accepted
18 Jan 2024 Article published 10.1186/s12883-023-03521-y

You can find further information about peer review here.

Back to article page